Cella, Marina http://orcid.org/0000-0003-1230-1313
Gamini, Ramya
Sécca, Cristiane http://orcid.org/0000-0003-4433-8962
Collins, Patrick L.
Zhao, Shanrong
Peng, Vincent
Robinette, Michelle L. http://orcid.org/0000-0003-0965-5225
Schettini, Jorge
Zaitsev, Konstantin http://orcid.org/0000-0003-3749-0886
Gordon, William
Bando, Jennifer K.
Yomogida, Kentaro
Cortez, Victor
Fronick, Catrina
Fulton, Robert
Lin, Lih-Ling
Gilfillan, Susan
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
Shan, Liang
Artyomov, Maxim N.
Bowman, Michael
Oltz, Eugene M.
Jelinsky, Scott A. http://orcid.org/0000-0002-5114-0236
Colonna, Marco http://orcid.org/0000-0001-5222-4987
Article History
Received: 23 July 2018
Accepted: 15 May 2019
First Online: 17 June 2019
Change Date: 6 August 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: R.G., S.Z., W.G., J.S., L.-L.L., M.B. and S.A.J. are Pfizer employees. M. Colonna received funding from Pfizer to study ILC biology in inflammatory bowel disease. The other authors declare no conflicts of interests.